Verdiva Bio
77 employees on LinkedIn · 4 known investors
Find your way into Verdiva Bio
Each arrow is one introduction. Sign up to fill in the first one.
Ask Wouter Joustra to introduce you to Jane Hughes
You →Wouter · together at Verdiva Bio →Jane
Sign up to find every way you can get introduced to Verdiva Bio
- Your email: who you already know at Verdiva Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Verdiva Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Verdiva Bio is a biotechnology company focused on drug development. Its leadership brings experience in in-licensing, commercialization, and business development across the international biotech industry.
Founders & leadership

Investors · 4
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Funding
SEC filings, press & company announcements$410M disclosed across 1 round · 2025
- $410MSeries AJan 2025 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Verdiva Bio do?
- Verdiva Bio is a biotechnology company focused on drug development. Its leadership brings experience in in-licensing, commercialization, and business development across the international biotech industry.
- Who are Verdiva Bio's investors?
- Verdiva Bio's investors include OrbiMed, RA Capital, Forbion, General Atlantic.
- How much funding has Verdiva Bio raised?
- Verdiva Bio has disclosed $410M raised across 1 round.





